Construct and longitudinal validity of a modified Huang clinical scoring system in adult cystic fibrosis patients

European Respiratory Journal

Volumn 13, Issue 3, 1999, Pages 552-559

  Matouk, E ^a   Ghezzo, R H ^a   Gruber, J ^a   Hidvegi, R ^a   Gray Donald, K ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Construct validity; Cystic fibrosis; Longitudinal validity; Questionnaires; Severity of illness index

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CYSTIC FIBROSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; FORCED EXPIRATORY FLOW; HUMAN; LUNG FUNCTION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS; SCORING SYSTEM; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS;

EID: 0032950672     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.99.13355299     Document Type: Article

References (33)

1. Boat TF, Welsh MJ, Beaudet AL. Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. New York, McGraw-Hill, 1989; pp. 2649-2680.
2. Marshall BC. Pathophysiology of pulmonary disease in cystic fibrosis. In: Petty TL, Cherniack RM, Fiel SB, eds. Seminars in Respiratory and Critical Care Medicine: Vol. 15; Cystic Fibrosis. New York and Stuttgart, Thieme Medical Publishers, 1994; pp. 364-374.
3. Burke W, Aitken ML. The ageing cystic fibrosis patient: presentations and problems. In: Petty TL, Cherniack RM, Fiel SB, eds. Seminars in Respiratory and Critical Care Medicine: Vol. 15; Cystic Fibrosis. New York and Stuttgart, Thieme Medical Publishers, 1994; pp. 383-390.
4. FitzSimmons SC. The changing epidemiology of cystic fibrosis. Pediatr 1993; 122: 1-9.
5. Collins FS. Cystic fibrosis: molecular biology and therapeutic implications. Science 1992; 256: 774-779.
6. Huang N, Helen HK, Palmer J, Hsuan F. A scoring system for short-term evaluation of patients with cystsic fibrosis: a possible means for assessment of antibiotic efficacy. In: Warwick WJ, ed. 1,000 years of Cystic Fibrosis Collected Papers, Minnesota University of Minnesota Dept of Pediatrics Medical School in cooperation with International Cystic Fibrosis Association National Heart Lung and Blood Institute and Fogarty International Center, 1981; pp. 207-215.
7. Matouk E, Ghezzo RH, Gruber J, Hidvegi R, Gray-Donald K. Internal consistency reliability and predictive validity of a modified N. Huang clinical scoring system in adult cystic fibrosis patients. Eur Respir J 1997; 10: 2004-2013.
8. Lacasse Y, Wong E, Guyatt G. A systematic overview of the measurement properties of the chronic respiratory questionnaire. Can Respir J 1997; 4: 131-139.
9. Guyatt G, Feeny DH. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622-629.
10. American Thoracic Society. Standardization of spirometry 1987 update. Am Rev Respir Dis 1987; 136: 1285-1295.
11. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983; 127: 725-734.
12. Wagener JS, Taussig LM, Burrows B, Hernried L, Boat T. Comparison of lung function and survival patterns between cystic fibrosis and emphysema or chronic bronchitis patients. In: Sturgess JM, ed. Perspectives in Cystic Fibrosis. Proceedings of the 8th International Cystic Fibrosis Congress. Mississauga, Ontario, Imperial Press, 1980; pp. 236-245.
13. McDowell I, Newell C. Measuring Health: A Guide to Rating Scales and Questionnaires. New York, NY, Oxford University Press, 1987.
14. Huang NN, Schidlow D, Szatrowski T, et al. Clinical features, survival rate and prognostic factors in young adults with cystic fibrosis. Am J Med 1987; 82: 871-879.
15. Kerem E, Corey M, Gold R, Levision H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr 1990; 116: 714-719.
16. Demko CA, Byard PJ, Davis PB. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 1995; 48: 1041-1049.
17. Mouton JW, Den-Hollander JG, Horrevorts AM. Emergence of antibiotics resistance amongst Pseudomonas aeruginosa isolates from patients with cystic fibrosis. J Antimicrob Chemother 1993; 31: 919-926.
18. Cooper P, Robertson C, Hudson I, Phelan P. Variability of pulmonary function tests of lung in cystic fibrosis. Pediatr Pulmonol 1990; 8: 16-22.
19. Brazier JE, Harper R, Jones NMB, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992; 305: 160-164.
20. Kirshner B, Guyatt G. A methodological framework for assessing health indices. J Chron Dis 1985; 38: 27-36.
21. Wong EB, Regnis J, Shier RC, Bye PT, Stewart ME. The relationship between tests of lung function and three chest radiological scoring systems in patients with cystic fibrosis. Austras Radiol 1993; 37: 265-269.
22. Conway SP, Pond MN, Bowler I, et al. The chest radiograph in cystic fibrosis: a new scoring system compared with the Chrispin-Norman and Brasfield scores. Thorax 1994; 49: 860-862.
23. Sawyer SM, Carlin JB, DeCampo M, Bowes G. Critical evaluation of three radiograph scores in cystic fibrosis. Thorax 1994; 49: 866-863.
24. Rosenberg SM, Howatt WF, Grum CM. Spirometry and chest roengenographic appearance in adults with cystic fibrosis. Chest 1992; 101: 961-964.
25. Beier R, Renzetti AD Jr, Mitchell M, Watanabe S. Pulmonary pathophysiology in cystic fibrosis. Am Rev Respir Dis 1966; 94: 430-440.
26. Matthews IW, Doershuk CF. Measurement of pulmonary function in cystic fibrosis. In: Rossi E, Stoll E, eds. Modem Problems in Pediatrics. Vol 10. New York, S Krager AG, 1967; p. 237.
27. Godfrey S, Mearns M. Pulmonary function and response to exercise in children with cystic fibrosis. Arch Dis Child 1971; 46: 144-157.
28. Featherby FA, Weng T-R, Crozier DN, Duic A, Reilly BJ, Levison H. Dynamic and static lung volumes, blood gas tensions and diffusing capacity in patients with cystic fibrosis. Am Rev Respir Dis 1970; 102: 737-749.
29. Wielinski CL, Warwick WJ, Budd JR. Mortality and progression of the NIH clinical and prognostic score. Pediatric Pulmonol 1990; 16: Suppl. 5, 259-260. (Abstract).
30. Guyatt GH, Thompson PJ, Berman LB, et al. How should we measure function in patients with chronic heart and lung disease? J Chron Dis 1985; 38: 517-524.
31. Wegener RE, Jorres RA, Kirsten DK, Magnussen H. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. Eur Respir J 1994; 7: 725-729.
32. Wijkistra PJ, Ten Vergert EM, van der Mark TW, et al. Relation of lung function, maximal inspiratory pressure, dyspnea and quality of life with exercise capacity in paients with chronic obstructive pulmonary disease. Thorax 1994; 49: 468-472.
33. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. Am Rev Respir Dis 1992; 145: 1321-1327.